News Industry News Esperion Therapeutics Announces Positive Top-Line Phase 2 Results for ETC-1002 in Patients With Hypercholesterolemia and Hypertension July 28, 2015
News Features Hay Oportunidades para Hospitales e Intervencionistas que Eviten Rehospitalizaciones Innecesarias July 28, 2015
News Industry News Study of Penumbra’s ACE64 Demonstrates High Revascularization Rates, Quick Procedure Times in Stroke Patients July 28, 2015
News Features Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions July 28, 2015
News Industry News ISIS Pharmaceuticals Reports Data from ISIS-TTR Rx in patients with Transthyretin Amyloid-Related Cardiomyopathy July 27, 2015
News Daily News Un Estudio Sugiere que Tener 90 Años o Más No Debería de Excluir la TAVR Todd Neale July 27, 2015
News Daily News Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR Todd Neale July 27, 2015